Hernández GCM, Sánchez AA, Kably AA

Language: Spanish
References: 15
Page: 11-15
PDF size: 203.41 Kb.

ABSTRACT

It is estimated that 21% of infertile couples are due to anovulation and oligoovulation. Ovulation induction refers to the type of ovarian stimulation for women with anovulation that aims to restore normal fertility by generating normoovulatory cycles. This literary review describes low complexity treatments; ovulation induction, intrauterine insemination alone and ovulation induction and intrauterine insemination; Ovulation induction medications, as well as indications and doses.

REFERENCES

1. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008; 99 (2): 63.

2. Li RH, Ng EH. Management of anovulatory infertility. Best Pract Res Clin Obstet Gynaecol. 2012; 26 (6): 757-768.

3. Kably AA, Salazar LC, Serviere ZC, Velázquez CG, Pérez PE, Santos HR, Luna RM et al. Consenso Nacional Mexicano de Reproducción Asistida. Ginecol Obstet Mex. 2012; 80 (9): 581-624.

4. McLaren JF. Infertility evaluation. Obstet Gynecol Clin North Am. 2012; 39 (4): 453-463.

5. Yen & Jaffe’s, Reproductive endocrinology, Chapter 30, 743-778.e7.

6. Gadalla MA, Huang S, Wang R, Norman RJ, Abdullah SA, El Saman AM et al. Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live 
birth in anovulatory women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018; 51 (1): 64-76.

7. 
Hughes E, Brown J, Collins JJ, Vanderkerchove PP. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2010; (1): CD000057.

8. Franik S, Kremer JA, Nelen WL, Farquhar C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2014; (2): CD010287.

9. Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014; 371 (2): 119-129. Erratum in: N Engl J Med 2014; 317 (15): 1465.

10. Remohi et al. Manual práctico de esterilidad y reproducción humana, aspectos clínicos. 5ª ed. Madrid: Editorial Médica Panamericana, 2018.

11. Steures P, van der Steeg JW, Hompes PG, Habbema JD, Eijkemans MJ, Broekmans FJ et al. Intrauterine insemination with controlled ovarian hyperstimulation versus EM for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial. Lancet. 2006; 368 (9531): 216-221.

12. Veltman-Verhulst SM, Cohlen BJ, Hughes E, Heineman MJ. Intrauterine insemination for unexplained subfertility. Cochrane Database Syst Rev. 2012; (9): CD001838.

13. Farquhar CM, Liu E, Armstrong S, Arroll N, Lensen S, Brown J. Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial. Lancet. 2018; 391 (10119): 441-450.

14. Cantineau AE, Janssen MJ, Cohlen BJ, Allersma T. Synchronised approach for intrauterine insemination in subfertile couples. Cochrane Database Syst Rev. 2014; (12): CD006942.

15. Kyrou D, Kolibianakis EM, Fatemi HM, Grimbizis GF, Theodoridis TD, Camus M, Tournaye H et al. Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study. Reprod Biomed Online. 2012; 25 (3): 278-283.